New insulin pump software tested in kids as young as 2

NCT ID NCT06717451

Ongoing Disease control Sponsor: Tandem Diabetes Care, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is checking how safe and effective an updated insulin pump system (Control-IQ 1.5) is for children ages 2 to 6 with type 1 diabetes. About 144 kids will use the pump for a year while researchers track dangerous low blood sugar events and diabetic ketoacidosis. The goal is to see if the technology helps keep blood sugar in a healthy range in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Control-IQ Technology v1.5 (insulin pump software)
What this could lead to: If successful, this could show that the updated pump system is safe and effective for very young children, helping them maintain better blood sugar control.
What could go wrong: This is a small, single-arm observational study with no comparison group, so results may not prove the device is better than other options. Risks include severe hypoglycemia or diabetic ketoacidosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Tandem Diabetes Care

San Diego, California, 92130, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.